---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-23-008752"
form_type: "8-K"
ticker: "COSM"
cik: "0001474167"
company_name: "Cosmos Health Inc."
filed_at: "2023-11-22T23:59:59+00:00"
generated_at: "2026-06-07T22:09:19.240139+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Cosmos Health Q3 2023: Revenue $12.8M (+7% YoY), net loss $3.35M, Adj. EBITDA -$1.1M

## Summary
- Revenue $12.8M (+7% YoY); gross margin declined to 9.5% from 14.9% due to logistics mix.
- Net loss $3.35M vs $1.97M in Q3 2022; Adjusted EBITDA -$1.1M vs +$0.5M.
- SG&A doubled to $4.0M on R&D, acquisition integration, stock-based comp, and provisions.
- Total assets record $71.5M; stockholders' equity $44.2M ($3.4/share); debt reduced.
- Reiterated 2026 guidance: >$180M revenue, >$20M EBITDA; plans to spin off R&D division.

## SEC filing metadata
- accession: 0001477932-23-008752
- form_type: 8-K
- ticker: COSM
- cik: 0001474167
- company_name: Cosmos Health Inc.
- filed_at: 2023-11-22T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1474167/000147793223008752/0001477932-23-008752-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1474167/000147793223008752/cosm_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-23-008752
- JSON: https://secwatch.observer/filing/0001477932-23-008752.json
- Plain text: https://secwatch.observer/filing/0001477932-23-008752.txt

## Key facts
- Earnings Releases
  Cosmos Health Inc. reported the third quarter and nine months ended September 30, 2023 results: revenue $12.8 million. Guidance reaffirmed.
  - Period: the third quarter and nine months ended September 30, 2023
  - Revenue: $12.8 million
  - Guidance: reaffirmed
  - Result: reported results
  source text: a business update and reported financial results for the third quarter and nine months ended September 30, 2023. Third Quarter 2023 Financial Highlights · Revenues increased to $12.8 million from $12.0 million in Q3 2022, largely due to increased sales attributable to the logistics distribution business, which expanded following the acquisition of the Bikas GP
  evidence_url: https://www.sec.gov/Archives/edgar/data/1474167/000147793223008752/0001477932-23-008752-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.